The South Africa minimally invasive surgical devices market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 7.3% during 2023–2031. The growth of the market is attributed to the increasing number of surgical & interventional procedures, growing improvements in the reimbursement, and streamlining of regulatory guidelines.
The minimally invasive surgeries are encompass surgical procedures that limit the size of incisions, effectively lessen the wound healing time, and reduce the risk of infection. Many operations require large incisions that referred to as open surgery, which can sometimes leave large wounds that are painful and take a long time to heal. In order to overcome the high risks associated with the traditional surgeries, the minimally invasive procedures have been practiced by the advancement of various medical technologies.
The minimally invasive surgeries have been reported to cause less post-operative pain and reduce the dosages of painkillers. The main advantage of the minimally invasive procedures over the traditional open surgeries is higher precision due to video-assisted equipment that aids in producing a clear and magnified image of the organs being operated. The minimally invasive procedures are gaining wider acceptance among the diabetic patients and the aging population owing to the relatively shorter recovery time and low risks of infection. The minimally invasive surgery causes less pain &scarring, speeds patient recovery, and reduces the incidence of post-surgical complications.
The special medical equipment used for minimally invasive surgeries include fiber optic cables, miniature video cameras, and special surgical instruments. The images of the interior body parts are transmitted to an external video monitor so that the surgeons can diagnosis by visually identifying internal features. The endovascular aneurysm repair is an example of minimally invasive surgery, which is much less invasive, involves much smaller incisions than the traditional open surgery procedure of open aortic surgery. Therefore, it has become the most common method of repairing abdominal aortic aneurysms.
The COVID-19 pandemic has affected almost every industry including the healthcare industry. The high risk of developing serious illness due to coronavirus disease has made it challenging for several other healthcare problems. The outbreak situation resulted into nationwide lockdowns, which disrupted the supply of healthcare facilities and manufacturing of surgical devices. The stringent regulations and slowdown in economy hampered the growth of the minimally invasive surgical devices market.
South Africa Minimally Invasive Surgical Devices Market Trends, Drivers, Restraints and Opportunities
-
Rising acceptance rate of minimally invasive procedures over traditional procedures and improved patient quality of life are the major factor propelling the market expansion during the projected period.
-
Increasing healthcare spending and rising prevalence of chronic disorders are expected to spur the growth of the market in the coming years.
-
Growing number of surgeries among the aging population is projected to support the growth of this market during the forecast period.
-
High cost associated with the surgical treatments is expected to hamper the growth of market during the forecast period.
-
Growing industrial investments for developing advanced surgery devices and increasing research & development activities for innovative product launches are expected to create lucrative opportunities for the market in the long run.
Scope of South Africa Minimally Invasive Surgical Devices Market Report
The report on the South Africa minimally invasive surgical devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Minimally Invasive Surgical Devices Market - South Africa Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Products (Handheld Instruments, Robotic Assisted Surgical Systems, Guiding Devices, Electrosurgical Devices, Monitoring & Visualization Devices, Ablation Devices, Endoscopic Devices, Laser-based Devices, Laparoscopic Devices, and Others) and Applications (Gastrointestinal, Orthopedic, Aesthetic, Gynecological, Urological, Cardiovascular, and Others)
|
|
Country
|
South Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Medtronic PLC; Abbott Laboratories; Siemens Healthineers; GE Healthcare; and Koninklijke Philips NV
|
South Africa Minimally Invasive Surgical Devices Market Segment Insights
Handheld instruments segment is projected to expand at a robust CAGR
Based on products, the market is segregated into handheld instruments, robotic assisted surgical systems, guiding devices, electrosurgical devices, monitoring & visualization devices, ablation devices, endoscopic devices, laser-based devices, laparoscopic devices, and others. The handheld instruments segment is projected to expand at a robust CAGR during the forecast period owing to the increasing demand for advanced surgical devices. Moreover, the rising demand for general surgeries such as appendectomy, breast biopsy, hysteroscopy, and low back pain surgery is anticipated to propel the growth of the market segment in the coming years.
On the other hand, the laparoscopic devices segment is anticipated to hold a significant market share during the forecast period due to the rising demand for diagnosis and therapeutic procedures of various diseases such as pancreatic cancer, prostatectomy, and gastrointestinal disorders. Furthermore, the increasing preference for laparoscopic devices by surgeons due to minimal bleeding and support for maintaining hemostasis is expected to boost the growth of the market segment during the forecast period.
Cardiovascular segment is projected to hold a significant market share
On the basis of applications, the market is segmented into gastrointestinal, orthopedic, aesthetic, gynecological, urological, cardiovascular, and others. The cardiovascular segment is projected to hold a significant market share during the forecast period due to the rising incidences of congenital heart defects, coronary artery disease, heart failure, valve disease, and electrophysiology. Moreover, the growing consumer disposable income, unhealthy diet, and changing lifestyle are some of the factors to boost the market segment growth in the coming years. On the other hand, the urological segment is anticipated to expand at a considerable pace owing to the increasing prevalence of urinary incontinence, pelvic organ prolapse, and overactive bladder and rising expenditure on medical surgeries. Furthermore, the increasing number of reconstructive surgeries is estimated to fuel the growth of the market during the projected timeline.
Segments
The South Africa minimally invasive surgical devices market has been segmented on the basis of
Products
- Handheld Instruments
- Robotic Assisted Surgical Systems
- Guiding Devices, Electrosurgical Devices
- Monitoring & Visualization Devices
- Ablation Devices
- Endoscopic Devices
- Laser-based Devices
- Laparoscopic Devices
- Others
Applications
- Gastrointestinal
- Orthopedic
- Aesthetic
- Gynecological
- Urological
- Cardiovascular
- Others
Country
Key Players
- Medtronic PLC
- Abbott Laboratories
- Siemens Healthineers
- GE Healthcare
- Koninklijke Philips NV
Competitive Landscape
Key players competing in the South Africa minimally invasive surgical devices market are Medtronic PLC; Abbott Laboratories; Siemens Healthineers; GE Healthcare; and Koninklijke Philips NV. Companies are focusing on growing manufacturing facilities, merger & acquisition activities, forming strong distribution networks with other industry players in order to expand their market shares.
-
In November 2021, Medtronic Plc planned to set up a global research & development center involving an investment of around USD 159 million at Hyderabad, India. The initiative facilitated the research work for medical products to treat over 70 health conditions that include cardiac devices, cranial & spine robotics, surgical tools, insulin pumps, patient monitoring systems, and others.
-
In June 2021, Abbott Laboratories launched its Amplatzer Piccolo™ Occluder in Mumbai, India. The Amplatzer Piccolo™ Occluder is the world's first medical device that can be implanted in the premature babies and newborns using a minimally invasive procedure to treat patent ductus arteriosus or PDA. The technology provided optimally-sized treatment through minimally invasive life-saving pediatric device with immediate impact, long-term benefits, reduced risks of life-threatening complications, and allow physicians to confidently treat the youngest and tiniest patients.
Request For Customization
Enquiry Before Buying
Speak With Analyst
